aldosterone has been researched along with Diabetic Angiopathies in 26 studies
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the factors that determine the blood pressure response to enalapril and nifedipine monotherapy in the treatment of hypertension associated with non-insulin-dependent diabetes mellitus (NIDDM)." | 9.08 | Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM. ( Chan, JC; Cheung, CK; Cockram, CS; Law, LK; Nicholls, MG; Swaminathan, R, 1995) |
| "In candesartan-treated db/db mice (1 mg/kg per day, 4 weeks) increased plasma aldosterone, CYP11B2 expression, and aldosterone secretion were reduced." | 5.38 | Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. ( Briones, AM; Burger, D; Burns, KD; Callera, GE; Corrêa, JW; Gagnon, AM; Gomez-Sanchez, CE; Gomez-Sanchez, EP; He, Y; Nguyen Dinh Cat, A; Ooi, TC; Ruzicka, M; Sorisky, A; Touyz, RM; Yogi, A, 2012) |
| "Mean captopril doses used were similar in both groups." | 5.27 | Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension. ( Dineen, M; Kelleher, M; Sullivan, PA; Twomey, M, 1985) |
| "To examine the factors that determine the blood pressure response to enalapril and nifedipine monotherapy in the treatment of hypertension associated with non-insulin-dependent diabetes mellitus (NIDDM)." | 5.08 | Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM. ( Chan, JC; Cheung, CK; Cockram, CS; Law, LK; Nicholls, MG; Swaminathan, R, 1995) |
| "We studied 30 patients with type 2 diabetes mellitus (mean age 43." | 2.73 | Gradual reactivation of vascular angiotensin I to angiotensin II conversion during chronic ACE inhibitor therapy in patients with diabetes mellitus. ( Morris, AD; Sharman, DC; Struthers, AD, 2007) |
| "Aldosterone is an important pathogenetic factor, independent of the renin-angiotensin system in cardiovascular and renal disease." | 2.73 | Aldosterone breakthrough during angiotensin II receptor blockade in hypertensive patients with diabetes mellitus. ( Karashima, S; Oda, N; Takata, H; Takeda, Y; Usukura, M; Yamagishi, M; Yamamoto, Y; Yoneda, T, 2007) |
| "In candesartan-treated db/db mice (1 mg/kg per day, 4 weeks) increased plasma aldosterone, CYP11B2 expression, and aldosterone secretion were reduced." | 1.38 | Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. ( Briones, AM; Burger, D; Burns, KD; Callera, GE; Corrêa, JW; Gagnon, AM; Gomez-Sanchez, CE; Gomez-Sanchez, EP; He, Y; Nguyen Dinh Cat, A; Ooi, TC; Ruzicka, M; Sorisky, A; Touyz, RM; Yogi, A, 2012) |
| "RFR was examined in 33 IDDM patients in similar glycaemic and metabolic control and compared to 12 healthy control subjects, during eight 1 h clearance periods prior to, during and after a 3-h stimulation by amino acid infusion (4." | 1.30 | Renal functional reserve in IDDM patients. ( Ader, JL; Hanaire-Broutin, H; Sackmann, H; Tack, I; Tauber, JP; Tran-Van, T, 1998) |
| "Mean captopril doses used were similar in both groups." | 1.27 | Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension. ( Dineen, M; Kelleher, M; Sullivan, PA; Twomey, M, 1985) |
| "Presence of moderately advanced diabetic nephropathy and autonomic neuropathy influenced only slightly WI induced alterations of the renin-aldosterone system and AVP secretion." | 1.27 | [Effect of water immersion on plasma renin activity, vasopressin and aldosterone level in diabetics]. ( Duława, J; Grzeszczak, W; Kokot, F; Wiecek, A, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (23.08) | 18.7374 |
| 1990's | 7 (26.92) | 18.2507 |
| 2000's | 10 (38.46) | 29.6817 |
| 2010's | 3 (11.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, T | 1 |
| Takai, S | 1 |
| Yamashita, C | 1 |
| Briones, AM | 1 |
| Nguyen Dinh Cat, A | 1 |
| Callera, GE | 1 |
| Yogi, A | 1 |
| Burger, D | 1 |
| He, Y | 1 |
| Corrêa, JW | 1 |
| Gagnon, AM | 1 |
| Gomez-Sanchez, CE | 1 |
| Gomez-Sanchez, EP | 1 |
| Sorisky, A | 1 |
| Ooi, TC | 1 |
| Ruzicka, M | 1 |
| Burns, KD | 1 |
| Touyz, RM | 1 |
| Bender, SB | 1 |
| McGraw, AP | 1 |
| Jaffe, IZ | 1 |
| Sowers, JR | 2 |
| Abbott, KC | 1 |
| Bakris, GL | 1 |
| McFarlane, SI | 1 |
| Mogensen, CE | 1 |
| Cooper, ME | 1 |
| Kalantarinia, K | 1 |
| Okusa, MD | 1 |
| Jefic, D | 1 |
| Mohiuddin, N | 1 |
| Alsabbagh, R | 1 |
| Fadanelli, M | 1 |
| Steigerwalt, S | 1 |
| Sharman, DC | 1 |
| Morris, AD | 3 |
| Struthers, AD | 2 |
| Yoneda, T | 1 |
| Takeda, Y | 1 |
| Usukura, M | 1 |
| Oda, N | 1 |
| Takata, H | 1 |
| Yamamoto, Y | 1 |
| Karashima, S | 1 |
| Yamagishi, M | 1 |
| Swaminathan, K | 1 |
| Davies, J | 1 |
| George, J | 1 |
| Rajendra, NS | 1 |
| Griaznova, IM | 1 |
| Kniazev, IuA | 1 |
| Vtorova, VG | 1 |
| Bespalova, VA | 1 |
| Kirbasova, NP | 1 |
| Vakov, L | 1 |
| Chan, JC | 1 |
| Nicholls, MG | 1 |
| Cheung, CK | 1 |
| Law, LK | 1 |
| Swaminathan, R | 1 |
| Cockram, CS | 1 |
| Lehnert, H | 1 |
| Schmitz, H | 1 |
| Preuss, K | 1 |
| Küstner, E | 1 |
| Krause, U | 1 |
| Beyer, J | 1 |
| Sackmann, H | 1 |
| Tran-Van, T | 1 |
| Tack, I | 1 |
| Hanaire-Broutin, H | 1 |
| Tauber, JP | 1 |
| Ader, JL | 1 |
| Flack, JM | 1 |
| Hamaty, M | 1 |
| Staffileno, BA | 1 |
| Petrie, JR | 1 |
| Ueda, S | 1 |
| Small, M | 1 |
| Donnelly, R | 1 |
| Connell, JM | 1 |
| Elliott, HL | 1 |
| Ferriss, JB | 1 |
| Björck, S | 1 |
| Aurell, M | 1 |
| Ueda, Y | 1 |
| Aoi, W | 1 |
| Yamachika, S | 1 |
| Shikaya, T | 1 |
| Sullivan, PA | 1 |
| Kelleher, M | 1 |
| Twomey, M | 1 |
| Dineen, M | 1 |
| Duława, J | 1 |
| Kokot, F | 1 |
| Grzeszczak, W | 1 |
| Wiecek, A | 1 |
| Baba, T | 1 |
| Murabayashi, S | 1 |
| Ishizaki, T | 1 |
| Ido, Y | 1 |
| Aoyagi, K | 1 |
| Takebe, K | 1 |
| Furitano, G | 1 |
| Bompiani, GD | 1 |
| Lanzarone, G | 1 |
| Laudicina, E | 1 |
| Scaduto, P | 1 |
9 reviews available for aldosterone and Diabetic Angiopathies
| Article | Year |
|---|---|
Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus.
Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Chymases; Diabetes Mellitus, Type 2; | 2010 |
Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?
Topics: Aldosterone; Animals; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Human | 2013 |
Treatment of the diabetic patient: focus on cardiovascular and renal risk reduction.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Aquaporins; Cardiovascular System; Diabetes M | 2002 |
Cardiovascular endocrinology 1: aldosterone function in diabetes mellitus: effects on cardiovascular and renal disease.
Topics: Aldosterone; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Renin | 2003 |
Diabetic renal disease: from recent studies to improved clinical practice.
Topics: Albuminuria; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood G | 2004 |
The renin-angiotensin system and its blockade in diabetic renal and cardiovascular disease.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascu | 2006 |
Renin-angiotensin-aldosterone-kinin system influences on diabetic vascular disease and cardiomyopathy.
Topics: Aldosterone; Animals; Cardiomyopathies; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Huma | 1998 |
The causes of raised blood pressure in insulin-dependent and non-insulin-dependent diabetes.
Topics: Aldosterone; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopat | 1991 |
Diabetes mellitus, the renin-angiotensin system, and angiotensin-converting enzyme inhibition.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diab | 1990 |
5 trials available for aldosterone and Diabetic Angiopathies
| Article | Year |
|---|---|
Gradual reactivation of vascular angiotensin I to angiotensin II conversion during chronic ACE inhibitor therapy in patients with diabetes mellitus.
Topics: Adult; Aged; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; B | 2007 |
Aldosterone breakthrough during angiotensin II receptor blockade in hypertensive patients with diabetes mellitus.
Topics: Aged; Albuminuria; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Co | 2007 |
Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles.
Topics: Aged; Aldosterone; Angiotensin II; Blood Glucose; Blood Pressure; Body Mass Index; Cross-Over Studie | 2008 |
Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
Topics: Albuminuria; Aldosterone; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Glucose; Blood P | 1995 |
Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes: a double-blind, placebo-controlled crossover trial.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; C | 2000 |
12 other studies available for aldosterone and Diabetic Angiopathies
| Article | Year |
|---|---|
Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction.
Topics: Adipocytes; Aldosterone; Animals; Benzimidazoles; Biphenyl Compounds; Calcineurin; Cells, Cultured; | 2012 |
The prevalence of primary aldosteronism in diabetic patients.
Topics: Aldosterone; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Hyperaldosteronism; H | 2006 |
Renin Academy hosts Topical Workshop session at ESH 2006.
Topics: Aldosterone; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Renin; Renin-Angiotensin System | 2006 |
[Osmotic homeostatic characteristics of pregnant women with diabetes mellitus and of their fetuses].
Topics: Aldosterone; C-Peptide; Circadian Rhythm; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diab | 1984 |
[Contrainsular hormones and diabetic microangiopathy].
Topics: Adrenal Cortex Hormones; Aldosterone; Animals; Capillary Permeability; Catecholamines; Diabetic Angi | 1984 |
Effects of nitrendipine on blood pressure, renin-angiotensin-system and atrial natriuretic peptide in hypertensive type I diabetic patients.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Diabetes Mellitus, Type 1; Diab | 1993 |
Renal functional reserve in IDDM patients.
Topics: Adult; Albuminuria; Aldosterone; Amino Acids; Blood Glucose; Blood Pressure; C-Peptide; Creatinine; | 1998 |
Beneficial effects of angiotensin-converting enzyme inhibitor on renal function and glucose homeostasis in diabetics with hypertension.
Topics: Aged; Aldosterone; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; | 1990 |
Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetic Angiopath | 1985 |
[Effect of water immersion on plasma renin activity, vasopressin and aldosterone level in diabetics].
Topics: Aldosterone; Arginine Vasopressin; Blood Volume; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type | 1987 |
Renal kallikrein in diabetic patients with hypertension accompanied by nephropathy.
Topics: Adult; Aged; Aldosterone; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; | 1986 |
[Rheography in the study of peripheral circulation. II. Modifications induced by aldosterone in the vasomotor response to muscular work in diabetics].
Topics: Adult; Aldosterone; Blood Flow Velocity; Diabetic Angiopathies; Humans; Physical Exertion; Vasomotor | 1966 |